首页> 外文OA文献 >Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: A double-blind, multicentre study
【2h】

Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: A double-blind, multicentre study

机译:西酞普兰与氟伏沙明在抑郁症门诊患者中的疗效和耐受性:双盲,多中心研究

摘要

In 16 depression clinics in hospitals and outpatient facilities in the Netherlands, a study was performed to evaluate and compare the efficacy and tolerability of citalopram and fluvoxamine and to determine the difference in the incidence of gastrointestinal side-effects. A total of 217 patients with a depressive disorder (DSM-III-R criteria) and a score of at least 16 on the Hamilton rating scale for depression were randomized to treatment. The results of this study indicate that the two drugs are equally effective. The adverse events occurring during treatment show a similar pattern between the two drugs, but citalopram is better tolerated than fluvoxamine. Citalopram induces fewer gastrointestinal adverse events compared with fluvoxamine. However, this did not affect the drop-out rates.
机译:在荷兰的16家医院和门诊设施的抑郁症诊所中,进行了一项研究,以评估和比较西酞普兰和氟伏沙明的疗效和耐受性,并确定胃肠道副作用的发生率之间的差异。共有217名抑郁症患者(DSM-III-R标准)且汉密尔顿抑郁量表评分至少为16分,被随机分配至治疗。这项研究的结果表明这两种药物是同等有效的。治疗期间发生的不良事件在两种药物之间显示出相似的模式,但西酞普兰比氟伏沙明耐受性更好。与氟伏沙明相比,西酞普兰诱导的胃肠道不良事件更少。但是,这并不影响辍学率。

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号